ABB India bags order to automate Reliance Life Sciences biopharmaceutical facilities Ruchika Sharma22 Aug 2023 4:00 PM ISTRLS' 160 acre facility at Nashik will house manufacturing plants for plasma proteins, biopharmaceuticals, oncology pharmaceuticals and vaccines.
CDSCO panel approves Reliance Life Science's Phase III CT Protocol for Tocilizumab Dr. Divya Colin9 April 2023 5:55 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved Reliance Life...
IIT Kanpur licenses gene therapy to Reliance Life Sciences MD Bureau11 March 2023 10:00 AM ISTThe gene therapy technology from IIT Kanpur will be further developed as an Indigenous Product by Reliance Life Sciences, said an official release...
Reliance Life Sciences gets DCGI approval for COVID vaccine trial Ruchika Sharma4 Sept 2021 1:36 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) on Friday granted permission to the Mukesh Ambani-owned Reliance Life Sciences to conduct...
